Collaboration in pharmacovigilance: lamotrigine and fatal severe cutaneous adverse reactions – a review of spontaneous reports

Collaboration in pharmacovigilance: lamotrigine and fatal severe cutaneous adverse reactions – a review of spontaneous reports

Neil Brickel,1 Haris Shaikh,1 Andrew Kirkham,2 Greg Davies,1 Michelle Chalker,1 Pascal Yoshida3 1Global Clinical Safety and Pharmacovigilance, GlaxoSmithKline, Uxbridge, Middlesex, UK; 2Classic and Established Products, GlaxoSmithKline, Brentford, Middlesex, UK; 3Clinical Safety and Post-marketing...

Full description

Bibliographic Details
Main Authors: Brickel N, Shaikh H, Kirkham A, Davies G, Chalker M, Yoshida P
Format: Article
Language:English
Published: Dove Medical Press 2017-07-01
Series:Therapeutics and Clinical Risk Management
Subjects:
Anti-epileptic drug
pharmacovigilance
Stevens-Johnson syndrome
toxic epidermal necrolysis
Drug Reaction with Eosinophilia and Systemic Symptoms
Online Access:https://www.dovepress.com/collaboration-in-pharmacovigilance-lamotrigine-and-fatal-severe-cutane-peer-reviewed-article-TCRM

Internet

https://www.dovepress.com/collaboration-in-pharmacovigilance-lamotrigine-and-fatal-severe-cutane-peer-reviewed-article-TCRM

Similar Items